Asia-Pacific Pharmaceutical Plastic Packaging Market

Asia-Pacific Pharmaceutical Plastic Packaging Market Analysis

The Asia-Pacific Pharmaceutical Plastic Packaging Market size is worth USD 15.67 Billion in 2025, growing at an 7.36% CAGR and is forecast to hit USD 22.36 Billion by 2030.

The region's dominance as home to the world's largest plastic producers ensures a steady supply of plastic materials, significantly impacting the sales of plastic packaging in the pharmaceutical sector. In 2023, Asia-Pacific produced over 50% of the world's total plastic output. Coupled with the region's rapidly growing pharmaceutical industry, this sets the stage for robust market growth.

• The demand for cost-effective and dependable packaging in pharmaceuticals propels the region's plastic packaging market. The diverse range of available monomers caters to various drugs, enhancing plastic's appeal in pharmaceuticals. Moreover, plastic containers increasingly replace glass for drug storage, minimizing breakage risks.
• Unit-dose packaging solutions, crucial for preventing dosage errors, are driving the demand for plastics in blisters and other formats like stick packs and pouches. Plastic's flexible and rigid packaging versatility offers added advantages for pharmaceutical manufacturers.
• As vaccine demand surges due to viral outbreaks, there's a corresponding rise in the need for disposable items like syringes and ampoules, driving the region's pharmaceutical plastic packaging market growth.
• Multinational pharmaceutical companies are expanding in the region, drawn by low manufacturing costs, accessible raw materials, and increasing healthcare spending. For instance, in May 2023, Aurigene Pharmaceutical Services, part of Dr. Reddy's Laboratories, invested USD 40 million to build a new biomanufacturing facility in India, focusing on therapeutic proteins, antibodies, and viral vectors.
• Government incentives for pharmaceutical production lure manufacturers and positively influence the packaging market. In March 2023, Inden Pharma's joint venture with ALPLA Group signaled its intent to broaden its reach beyond Europe, targeting markets like India and the United States. This expansion aims for a three-fold increase in annual production, targeting 800 million pharmaceutical packaging products over the next five years.

Asia-Pacific Pharmaceutical Plastic Packaging Market Trends

Rising Diabetes Rates Propel Growth in Pharmaceutical Plastic Packaging Market

• The rising number of diabetic patients in the region is set to significantly influence the growth of the pharmaceutical plastic packaging market during the forecast period. Daily insulin injections for type-1 diabetes patients utilize single-use syringes and needles, necessitating their disposal after use. This trend is anticipated to boost the sales of disposable plastic syringes in the region.
• The International Diabetes Federation (IDF) projects a 68% rise in diabetic individuals in Southeast Asia, reaching 151.5 million by 2045. Furthermore, diabetes-related health expenditures are forecasted to hit USD 17.68 billion in 2030 and USD 21.20 billion by 2045.
• Diabetic individuals face heightened risks of dental issues, including fungal infections, gum abscesses, and tooth decay. Consequently, there's an uptick in the use of dental products like dental floss, fluoride toothpaste, and interdental cleansers. These products, often packaged in plastic containers or laminated tubes, will see a surge in demand, directly benefiting the pharmaceutical plastic packaging sector.
• Government initiatives supporting diabetic patients have led to a surge in demand for insulin and other diabetic medicines, bolstering the growth of the target market. For instance, the Government of India provides free essential medicines, including insulin, through initiatives like Generic Medicines under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) and the Free Drug Service of the National Health Mission (NHM).
• Regional advancements in diabetes medications are set to propel the pharmaceutical plastic packaging market. For instance, in October 2023, Glenmark Pharmaceuticals Ltd unveiled a triple-drug fixed-dose combination for type-2 diabetics in India.

Growing Ageing Population and Surge in Number of Pharmaceutical Companies in China

• China's burgeoning pharmaceutical industry will bolster the pharmaceutical plastic packaging market. This growth not only broadens the market for packaging materials but also spurs innovation and heightens the demand for specialized, compliant packaging solutions. As the pharmaceutical sector expands, it opens avenues for the packaging industry to adapt and meet the evolving needs of this burgeoning market.
• As per the Forbes Global 2000 Ranking, the top ten Chinese pharmaceutical firms boasted a combined market value of approximately USD 183.97 billion in June 2023. With the pharmaceutical industry's growth trajectory, the demand for packaging materials is poised for a substantial uptick. Given its renowned barrier properties and capability to preserve medication stability, pharmaceutical plastic packaging is set to see heightened demand alongside the industry's expansion.
• China's fragmented pharmaceutical landscape is gearing up for heightened competitiveness in the coming years. Historically a manufacturing hub, China is now pivoting toward becoming a strategic research and development nucleus, driven by its robust growth in the healthcare sector.
• China's aging demographic is fueling a surging demand for drugs, a trend that Western pharmaceutical giants are keen to tap into. The World Health Organization (WHO) projects that 2040 individuals aged 60 and above will constitute 28% of China's population.
• Foreign pharmaceutical companies are increasingly eyeing the Chinese market. The nation has rolled out the welcome mat for foreign direct investment (FDI) in its pharmaceutical sector, especially in production and R&D facilities. This openness is evident as multinational corporations pour substantial investments into China and embark on major R&D initiatives, underscoring a bullish sentiment on the country's packaging pharma supply needs.

Asia-Pacific Pharmaceutical Plastic Packaging Industry Overview

The Asia-Pacific pharmaceutical plastic packaging market is fragmented. Various local and global pharmaceutical plastic packaging manufacturers have their presence in the Asia-Pacific region to benefit from the easy availability of raw materials and low production and labor costs. The low entry barrier in the region gained popularity among packaging companies to establish their presence in the region.

In April 2024, Berry Global Group Inc. celebrated the first anniversary of its cutting-edge healthcare manufacturing facility and Global Centre of Excellence in India. This new facility bolstered the company's capacity to assist regional healthcare firms and offer expertise in crafting advanced healthcare solutions.

Asia-Pacific Pharmaceutical Plastic Packaging Market Leaders

Asia-Pacific Pharmaceutical Plastic Packaging Market News

• March 2024: Berry Global Group Inc. celebrated the first anniversary of its groundbreaking child-resistant closure. This closure, equipped with cutting-edge digital technology, is tailored for drug development, clinical trials, research, and academic studies, significantly enhancing medication adherence.
• February 2024: Shriji Polymers (India) Limited, a prominent player in rigid plastic packaging solutions for the pharmaceutical sector, commemorated a year since its investment in Parekhplast India Limited. This strategic move is poised to bolster Shriji's foothold in the rigid plastic packaging.